The data forecasts a declining trend in the re-import of acyclic amides to Canada from 2024 to 2028. In 2023, the re-import value stood at 273.5 kilograms, marking a significant decrease ahead. The year-on-year percentage shows a consistent drop: decreasing by approximately 15.6% from 2024 to 2025, 18.1% from 2025 to 2026, and 21.6% from 2026 to 2027. The projected compound annual growth rate (CAGR) from 2024 to 2028 is approximately -21.5%, indicating a substantial average annual decline over this period.
Future trends to watch for include advancements in local production capacities and shifts in global supply chains. These factors could strongly influence import needs, alongside evolving regulatory environments and demand patterns in pharmaceutical and industrial sectors.
